Quality of life St George's Respiratory Questionnaire (SGRQ) score · acute exacerbations of chronic obstructive pulmonary disease
1 finding from 1 review
Depression score · acute exacerbations of chronic obstructive pulmonary disease
1 finding from 1 review
Intervention not reported
Postoperative mortality · people with surgical treatment for periampullary or pancreatic carcinoma
The intervention showed no clear difference in postoperative mortality (moderate certainty).
1 finding from 1 review
Intervention not reported
Pancreatic fistula · people with surgical treatment for periampullary or pancreatic carcinoma
The intervention showed no clear difference in pancreatic fistula (low certainty).
1 finding from 1 review
Intervention not reported
DGE · people with surgical treatment for periampullary or pancreatic carcinoma
The intervention may leads to higher DGE (low certainty).
1 finding from 1 review
Intervention not reported
Overall survival · people with surgical treatment for periampullary or pancreatic carcinoma
The intervention showed no clear difference in overall survival (low certainty).
1 finding from 1 review
Intervention not reported
Intraoperative blood loss (millilitres) · people with surgical treatment for periampullary or pancreatic carcinoma
The intervention showed no clear difference in intraoperative blood loss (millilitres) (low certainty).
1 finding from 1 review
Intervention not reported
Red blood cell transfusion (units) · people with surgical treatment for periampullary or pancreatic carcinoma
The intervention showed no clear difference in red blood cell transfusion (units) (low certainty).
1 finding from 1 review
Intervention not reported
Operating time (minutes) · people with surgical treatment for periampullary or pancreatic carcinoma
The intervention showed no clear difference in operating time (minutes) (low certainty).
1 finding from 1 review
Intervention not reported
Breathlessness ‐ all trials Lower score indicates improvement in breathlessness · patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy
1 finding from 1 review
Intervention not reported
Breathlessness ‐ subgroup analysis ‐ studies using short‐burst oxygen Lower score indicates improvement in breathlessness · patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy
1 finding from 1 review
Intervention not reported
Breathlessness ‐ subgroup analysis ‐ studies not using short‐burst oxygen Lower score indicates improvement in breathlessness · patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy
1 finding from 1 review
Intervention not reported
Breathlessness ‐ subgroup analysis ‐ studies measuring during exercise test Lower score indicates improvement in breathlessness · patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy
1 finding from 1 review
Intervention not reported
Breathlessness ‐ subgroup analysis ‐ studies not measuring during exercise test Lower score indicates improvement in breathlessness · patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy
1 finding from 1 review
Intervention not reported
Health‐related quality of life ‐ all trials Higher scores indicate improved health‐related quality of life · patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy
1 finding from 1 review
Mortality (all‐cause) · patients with chronic obstructive pulmonary disease
Tiotropium + LABA/ICS combination showed no clear difference in mortality (all‐cause) compared with tiotropium (moderate certainty).
1 finding from 1 review
Hospital admissions · patients with chronic obstructive pulmonary disease
Tiotropium + LABA/ICS combination showed no clear difference in hospital admission (all causes) compared with tiotropium (low certainty).
1 finding from 1 review
Exacerbations · patients with chronic obstructive pulmonary disease
Tiotropium + LABA/ICS combination showed no clear difference in exacerbation ‐ at 12‐month compared with tiotropium (low certainty).
1 finding from 1 review
Non‐fatal serious adverse events · patients with chronic obstructive pulmonary disease
Tiotropium + LABA/ICS combination showed no clear difference in serious adverse events (non‐fatal) compared with tiotropium (low certainty).
1 finding from 1 review
Quality of life St George's Respiratory Questionnaire (SGRQ) score · patients with chronic obstructive pulmonary disease
1 finding from 1 review